Search clinical trials for: Naloxone Nasal Spray

Total 3207 results

National Institute on Drug Abuse (NIDA)
New York MDRU

Completed

Buprenorphine and Naloxone Combination Study - 10

Opioid-Related Disorders | Heroin Dependence

United States
National Institute of Allergy and Infectious Diseases...
National Institute on Drug Abuse (NIDA)

Terminated

Drug Treatment Combined With Drug and Risk Reduction Counseling to Prevent of HIV Infection and Death Among Injection Drug Users

HIV Infections | Opioid-Related Disorders

China, Thailand
New York State Psychiatric Institute

Completed

Prescription Opioid Abuse Among Pain Patients: Predictors of Relapse (PAIN)

Opioid Dependence

United States
Mundipharma Research GmbH & Co KG

Completed

A Randomised, Double Blind, Placebo and Active Controlled, Double Dummy,Parallel Group Study to Determine the Safety and Efficacy of Oxycodone/Naloxone Prolonged Release Tablets in Subjects With Moderate to Severe, Chronic Nonmalignant Pain

Subjects With Moderate to Severe, Chronic Nonmalignant Pain
Zekai Tahir Burak Women's Health Research and Education...

Unknown

Comparison of Nasal CPAP and Nasal SIMV in Transient Tachypnea of Newborn

Transient Tachypnea of Newborn

Turkey
UCB Pharma

Completed

Efficacy, Safety and Tolerability of Rotigotine Nasal Spray for the Acute Treatment of Parkinson Symptoms

Parkinson's Disease
Imperial College London
Novartis Pharmaceuticals

Completed

Repeat Nasal Allergen Challenge

Hayfever

United Kingdom
Centre hospitalier de l'Université de Montréal...

Active, not recruiting

Dupilumab for Prevention of Recurrence of CRSwNP After ESS

Chronic Rhinosinusitis With Nasal Polyps

Canada
Apotex Inc.

Completed

A Study Comparing The Bioequivalence Of Ciclesonide Nasal Spray (Apotex, Inc.) To That Of Omnaris™ Nasal Spray (Sepracor, Inc.) In The Treatment Of Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis
Milton S. Hershey Medical Center

Withdrawn

Buprenorphine Induction for Fentanyl Dependent Opioid Users

Opioid Dependence Fentanyl

United States
NYU Langone Health
Emergency Medicine Foundation

Completed

Buprenorphine Loading in the Emergency Department

Opioid-use Disorder

United States
University of California, Los Angeles

Completed

Buprenorphine/Naloxone Versus Clonidine for Outpatient Opiate Detoxification - 1

Heroin Dependence | Substance Withdrawal Syndrome | Morphine Dependence

United States
MEDA Pharma GmbH & Co. KG

Completed

Azelastine Allergen Chamber - Onset of Action Study

Seasonal Allergic Rhinitis

Canada
Universitaire Ziekenhuizen KU Leuven

Unknown

Comparison of Cold Dry Air Exposure, Discs and Capsaicin

Nasal Hyper Reactivity

Belgium
Norwegian University of Science and Technology
St. Olavs Hospital

Completed

Pharmacodynamics and Arteriovenous Differences of Naloxone in Healthy Participants Exposed to an Opioid (OPI-15-001)

Drug Overdose

Norway
Massachusetts General Hospital

Not yet recruiting

A Prospective, Randomized Trial of the Effect of Standard of Care Reduced Dose Versus Full Dose Buprenorphine/Naloxone in the Perioperative Period on Pain Control and Post-Operative Opioid Use Disorder Symptoms

Opioid-use Disorder | Opioid Use Disorder, Mild
The University of Hong Kong

Completed

Effectiveness of a Chlorine Dioxide Spray on Dental Plaque and Respiratory Pathogens in Institutionalized Elders

Oral Hygiene | Frail Elderly | Nursing Homes | Chlorhexidine
Certmedica International GmbH

Completed

The Artificial Saliva Spray Reduces Xerostomia in Diabetes Type II

Diabetes Mellitus, Type 2 | Xerostomia Due to Hyposecretion of Salivary Gland

Italy
Aardvark Medical Company

Completed

Home Usability of a Nasal Lavage System in Children

Sinusitis | Allergic Rhinitis | Nasal Congestion | Respiratory Tract Infection

United States
US Endoscopy Group Inc.

Completed

trūFreeze® Spray Cryotherapy Patient Registry

Barrett Esophagus | Esophageal Neoplasm | Esophageal Stenosis | Esophageal Dysplasia | Bronchial Neoplasm | Stenosis of Bronchus or Trachea

United States
C.R.Darnall Army Medical Center

Completed

Ease-it Spray for the Treatment of Fire Ant Stings

Insect Bites and Stings
University of Texas Southwestern Medical Center
American Heart Association

Recruiting

Heat Waves and the Elderly With COPD

Hyperthermia | Aging | COPD

United States
Pherin Pharmaceuticals, Inc.

Completed

Intranasal PH94B for Management of the Symptoms of Generalized Social Phobia (PH94B-SAD)

Social Anxiety Disorder | Social Phobia

United States
Humanis Saglık Anonim Sirketi

Completed

Bioequivalence Study of Azelastine Hydrochloride/ Fluticasone Propionate 137 Microgram/50 Microgram Nasal Spray and Dymista Nasal Spray

Perennial Allergic Rhinitis | Seasonal Allergic Rhinitis

India
University of Bologna

Completed

Efficacy of Oral Leukotriene in Long Term Therapy of Mild and Moderate Obstructive Sleep Apnea Syndrome in Children (SB-OSAS)

Obstructive Sleep Apnea Syndrome

Italy
Meda Pharmaceuticals

Completed

A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Seasonal Allergies

Seasonal Allergic Rhinitis

United States
CBT4CBT, LLC

Completed

CBT4CBT for Office Based Buprenorphine

Opioid-use Disorder

United States
Yale University
National Institute on Drug Abuse (NIDA); Howard University; George Mason University

Completed

HIV, Buprenorphine, and the Criminal Justice System (STRIDE)

Acquired Immunodeficiency Syndrome | Human Immunodeficiency Virus | Opiate Addiction | Drug Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine/Naloxone Stabilization and Induction Onto Injection Naltrexone

Opioid Dependence

United States
Indivior Inc.

Completed

Acceptability and Safety of Switching From Subutex or Other Opioid Drug Dependence Therapy to Suboxone (NIS P05444)

Opioid-Related Disorders | Drug Abuse | Opiate Dependence

Austria
Mundipharma Research GmbH & Co KG

Completed

Optimisation of Hydromorphone - Naloxone Ratio for the Treatment of Pain (HMX3501)

Constipation

Romania, Switzerland, Israel, Belgium, Germany, Australia, Austria, Czech Republic, Denmark, Finland, France, Netherlands, Poland, United Kingdom
Entegrion, Inc.

Completed

Safety Study of Spray-Dried Solvent/Detergent-Treated Plasma for Infusion in Healthy Volunteers

Coagulation Defects

United States
Yuejia Pharmaceuticals (USA), Inc.
Zhejiang Yuejia Pharmaceuticals Co., Ltd.

Completed

Single-Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of YJ001 in Healthy Volunteers

Safety and Tolerability

United States
University of Florida

Withdrawn

Faces: Choices Study

Socioemotional Aging

United States
New York State Psychiatric Institute
Alkermes, Inc.

Terminated

Buprenorphine Stabilization and Induction Onto Vivitrol for Heroin-dependent Individuals

Heroin Dependence

United States
Unity Health Toronto
University of Toronto; Toronto Public Health; Ontario College of Art and Design...

Withdrawn

Surviving Opioid Overdose With Naloxone Education and Resuscitation Trial (SOONER) (SOONER)

Opioid-Related Disorders | Opioid Use | Education | Opioid Withdrawal | Opioid Overdose | Resusitation

Canada
NanoSHIFT LLC

Completed

A Single-Dose Study of an Investigational Capsule Formulation of 2 mg/0.5 mg Buprenorphine/Naloxone

Healthy

United States
University of California, Los Angeles

Completed

Buprenorphine/Naloxone Versus Clonidine for Inpatient Opiate Detoxification - 1

Heroin Dependence | Substance Withdrawal Syndrome | Morphine Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Recruiting

Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use Disorder (COMBO)

Opioid-use Disorder

United States
University of California, Davis
Yale University; University of Utah

Not yet recruiting

Feasibility of Pediatric Emergency Department-Initiated Treatment for Adolescents With Opioid Use Disorder (PEDsTREATOUD)

Opioid-use Disorder
MedicaSafe, Inc.
Friends Research Institute, Inc.

Unknown

Improving Office Based Treatment of Opioid Use Disorder With Technology

Opioid-use Disorder

United States
Massachusetts General Hospital

Unknown

Effect of Buprenorphine/Naloxone Continuation on Pain Control and Opioid Use

Surgery | Pain, Acute | Opioid-use Disorder
National Institute on Drug Abuse (NIDA)
Organization to Achieve Solutions in Substance Abuse (OASIS)

Completed

Bridging Active Heroin Users to Hepatitis C Treatment Using Buprenorphine - 1

Hepatitis C | Heroin Dependence

United States
Indivior Inc.
Taipei City Psychiatric Center, Taiwan

Completed

Multicentre Trial of Suboxone in Opiate-dependent Subjects in Taiwan

Opiate Dependence

Taiwan
Indivior Inc.

Completed

Treatment of Opioid Dependent Patients With Suboxone: Acceptability & Safety Data From Real Life Scenario (Study P05603)

Opioid-Related Disorders | Drug Abuse | Opiate Dependence
Puressentiel
University Hospital, Montpellier

Unknown

Efficacy of Nasal Spray Hypertonic Puressentiel on Symptoms of Allergic Rhinitis (ENAPAR)

Allergic Rhinitis

France
Universitaire Ziekenhuizen KU Leuven

Unknown

Comparison Between 4 Different Nasal Dilators

Incompetence of Nasal Valve

Belgium
University Hospital Ostrava
University of Ostrava

Recruiting

Nasal Obstruction Compared by Rhinomanometry and Nasal Inspiratory Peak Flow After Endoscopic Nasal Surgery

Nasal Obstruction | Pituitary Adenoma Invasive

Czechia
GlaxoSmithKline

Completed

Exploratory Subjective Sleep Study of a Prototype Nasal Dilator

Sleep Disorders | Congestion, Nasal

United States
Intersect ENT

Completed

S8 Sinus Implant in Chronic Sinusitis Patients With Recurrent Nasal Polyps (RESOLVE_II)

Chronic Sinusitis | Nasal Polyposis

United States

Search clinical trials for: Naloxone Nasal Spray

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Benin

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations